| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.072 | 0.8 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |